An HSV-1 test detects herpes simplex virus type 1, the virus responsible for most cold sores and an increasing share of genital herpes cases. There are two main approaches: a swab test taken directly from an active sore, and a blood test that looks for antibodies your immune system has built against the virus. Which test you get depends largely on whether you have visible symptoms at the time.
Swab Tests: PCR and Viral Culture
If you have a blister or sore, a provider will use a swab to collect fluid from it. The sore needs to be fresh, not already crusted over or healing, because the amount of virus drops quickly as a lesion dries out. That fluid sample can then be analyzed in one of two ways.
A PCR test searches for the virus’s genetic material in the sample. It is both faster and significantly more accurate than the older method, viral culture. In comparative studies, PCR achieved 100% sensitivity and 100% specificity for detecting HSV-1 and HSV-2, while viral culture caught only about 50% of positive cases. Because of that gap, PCR has largely replaced culture as the preferred swab test in most labs, though some clinics still offer culture depending on availability and cost.
Viral culture works by placing the sample in a lab dish and waiting for the virus to grow. If HSV is present, it will eventually show up in the culture. The downside is time (results can take several days) and the high miss rate, especially if the sore was already starting to heal when sampled.
Blood Tests for HSV-1 Antibodies
When there are no visible sores, a blood test is the only option. Rather than looking for the virus itself, blood tests detect antibodies, proteins your immune system produces in response to infection. There are two types of antibodies that matter here.
IgM antibodies appear early in an infection and signal a recent exposure. IgG antibodies develop later and stick around for life, indicating that you were infected at some point in the past. Most standard HSV blood tests look for IgG, because IgM testing is less reliable and harder to interpret. A single IgG level tells you whether you’ve been exposed, but it cannot pinpoint when the infection happened or whether it’s currently active.
Modern type-specific blood tests use a protein on the virus’s surface called glycoprotein G to distinguish between HSV-1 and HSV-2. The versions of this protein on each virus type are different enough that the test can tell them apart with high accuracy. HSV-1 antibodies are detected through the gG1 marker, while HSV-2 antibodies are detected through gG2. This matters because older, non-type-specific tests could only tell you that you had “herpes” without specifying which type.
When Antibodies Become Detectable
Blood tests have a window period. After a first-time HSV-1 infection, your body needs time to build detectable antibodies. That window is typically 2 to 12 weeks, with IgG antibodies first appearing around 7 to 14 days after infection and reaching peak levels about 4 to 6 weeks later. If you test too early, you may get a negative result even though you’re infected. For the most reliable results, waiting at least 12 weeks after a suspected exposure gives your immune system enough time to produce antibodies at levels the test can pick up.
Reading Your Results
Blood test results are reported as an index value. A result of 1.10 or higher is generally considered positive by most lab manufacturers. Below that threshold is negative. Some labs also report an equivocal or borderline range for values that fall near the cutoff.
The tricky part is low-positive results, values that clear the 1.10 threshold but not by much. These carry a higher risk of being false positives, especially for HSV-2 testing. If your result falls in a low-positive range and doesn’t match your symptoms or risk profile, your provider may recommend a confirmatory test that uses a different method to verify the result.
A positive swab test is more straightforward. If PCR or culture finds the virus in fluid from a sore, that’s a direct detection of HSV, not an indirect marker like antibodies. False positives on swab tests are extremely rare.
Why Routine Screening Isn’t Standard
You might assume that HSV-1 testing is part of a standard STI panel, but it typically isn’t. The CDC does not recommend routine herpes screening for people without symptoms. The main reasons are practical: a large majority of adults carry HSV-1 (often from childhood exposure through non-sexual contact), most never develop symptoms, and a positive blood test cannot tell you where on the body the virus lives or whether you’ll ever have an outbreak. For many people, a positive result creates anxiety without changing medical management.
Testing is most useful when you have an active sore that needs identification, when a sexual partner has been diagnosed with herpes, or when you’re experiencing recurring symptoms that could be herpes but haven’t been confirmed. In those situations, knowing your HSV-1 status helps guide decisions about treatment and reducing transmission risk.
What Each Test Can and Cannot Tell You
A swab test confirms that an active sore is caused by HSV-1 (or HSV-2). It tells you the virus type and proves it’s present right now. It cannot be performed without a visible lesion.
A blood test tells you whether you’ve been exposed to HSV-1 at some point in your life. It cannot tell you when you were infected, whether you’re currently contagious, where on your body the virus resides, or how often (if ever) you’ll have outbreaks. Once you test positive for HSV-1 IgG, you will test positive for the rest of your life, because those antibodies persist indefinitely.
If you’re getting tested after a specific exposure, the combination of timing and test type matters. A swab during an active outbreak gives the clearest answer. A blood test taken at least 12 weeks after exposure gives reliable information about whether your body has encountered the virus. Testing before that window closes risks a misleading negative result.